Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.

Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).

Findings seen in patients following myocardial infarction. (HealthDay News) — Beta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial infarction ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

Findings seen for individuals undergoing revascularization after non-ST-segment elevation myocardial infarction ...

Mohammad Ali Sheffeh, MD, from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the efficacy of GLP-1 RA or SGLT-2i initiation for reducing mortality or cardiovascular events among ...

(HealthDay News) — There is a small inverse association between plasma omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) and cancer, according to a study published online in the International ...

Extending wait time criteria from 1 to 3 hours after withdrawal of life-sustaining treatment for kidney donation after circulatory death (DCD) does not compromise kidney transplant outcomes and may ...

Investigators report a survival benefit with primary tumor ablation in patients with mRCC compared with no local treatment.

Preclinical studies have shown AT-02 is able to bind to multiple amyloid types and can induce macrophage mediated amyloid phagocytosis and removal. The Food and Drug Administration has granted Orphan ...